45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
11,844
Insurances with rates
75
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
056
$371,374
DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MCC
Gross
$371,374
RX-400446
$266,583
CABAZITAXEL 60 MG/6 ML (DILUTED) IV SOLN
Gross
$266,583
057
$189,926
DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MCC
Gross
$189,926
RX-99522
$167,926
PEGLOTICASE 8 MG/ML IV SOLN
Gross
$167,926
239
$166,540
AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH MCC
Gross
$166,540
093
$141,510
OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT CC/MCC
Gross
$141,510
RX-128898
$112,916
OCRELIZUMAB 300 MG/10ML IV SOLN
Gross
$112,916
155
$109,730
OTHER EAR, NOSE, MOUTH AND THROAT DIAGNOSES WITH CC
Gross
$109,730
391
$98,547
ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MCC
Gross
$98,547
280
$92,540
ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC
Gross
$92,540
726
$91,231
BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC
Gross
$91,231
RX-97701
$86,427
CABAZITAXEL 60 MG/1.5ML IV SOLN
Gross
$86,427
RX-152966
$86,250
NADOFARAGENE FIRADENOVEC-VNCG 300000000000 VP/ML IS SUSP
Gross
$86,250
475
$85,959
AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH CC
Gross
$85,959
884
$81,459
ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY
Gross
$81,459
RX-141155
$76,276
PERTUZ-TRASTUZ-HYALURON-ZZXF 80-40-2000 MG-MG-U/ML SC SOLN
Gross
$76,276
329
$73,260
MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MCC
Gross
$73,260
516
$68,684
OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH CC
Gross
$68,684
629
$65,683
OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH CC
Gross
$65,683
617
$64,552
AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH CC
Gross
$64,552
042
$63,676
PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITHOUT CC/MCC
Gross
$63,676
876
$63,244
O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS
Gross
$63,244
RX-125039
$62,569
ATEZOLIZUMAB 1200 MG/20ML IV SOLN
Gross
$62,569
853
$61,107
INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC
Gross
$61,107
RX-134503
$60,751
CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN
Gross
$60,751
RX-103786
$60,203
BRENTUXIMAB VEDOTIN 50 MG IV SOLR
Gross
$60,203
252
$57,568
OTHER VASCULAR PROCEDURES WITH MCC
Gross
$57,568
RX-140530
$57,118
DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN
Gross
$57,118
064
$55,370
INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC
Gross
$55,370
486
$55,317
KNEE PROCEDURES WITH PRINCIPAL DIAGNOSIS OF INFECTION WITH CC
Gross
$55,317
288
$54,543
ACUTE AND SUBACUTE ENDOCARDITIS WITH MCC
Gross
$54,543
374
$54,398
DIGESTIVE MALIGNANCY WITH MCC
Gross
$54,398
RX-430040
$54,050
LETS GEL KIT
Gross
$54,050
296
$51,862
CARDIAC ARREST, UNEXPLAINED WITH MCC
Gross
$51,862
542
$51,127
PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MCC
Gross
$51,127
RX-141154
$50,848
PERTUZ-TRASTUZ-HYALURON-ZZXF 60-60-2000 MG-MG-U/ML SC SOLN
Gross
$50,848
478
$50,122
BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC
Gross
$50,122
656
$47,917
KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC
Gross
$47,917
867
$47,346
OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC
Gross
$47,346
RX-115920
$47,206
OBINUTUZUMAB 1000 MG/40ML IV SOLN
Gross
$47,206
RX-45400
$47,204
NATALIZUMAB 300 MG/15ML IV CONC
Gross
$47,204
RX-10681
$46,999
ALTEPLASE 100 MG IV SOLR
Gross
$46,999
RX-122173
$46,340
INTERFERON BETA-1A 30 MCG/0.5ML IM PSKT
Gross
$46,340
645
$46,255
ENDOCRINE DISORDERS WITHOUT CC/MCC
Gross
$46,255
843
$44,833
OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC
Gross
$44,833
RX-136068
$43,798
ATEZOLIZUMAB 840 MG/14ML IV SOLN
Gross
$43,798
RX-131670
$43,728
NIVOLUMAB 240 MG/24ML IV SOLN
Gross
$43,728
474
$43,711
AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH MCC
Gross
$43,711
RX-24801
$43,667
LEUPROLIDE ACETATE (4 MONTH) 30 MG IM KIT
Gross
$43,667
503
$43,426
FOOT PROCEDURES WITH MCC
Gross
$43,426
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 056 | DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MCC | $371,374 | $371,374 | — | — | 4 |
| RX-400446 | CABAZITAXEL 60 MG/6 ML (DILUTED) IV SOLN | $266,583 | $266,583 | — | — | 22 |
| 057 | DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MCC | $189,926 | $189,926 | — | — | 6 |
| RX-99522 | PEGLOTICASE 8 MG/ML IV SOLN | $167,926 | $167,926 | — | — | 2 |
| 239 | AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH MCC | $166,540 | $166,540 | — | — | 1 |
| 093 | OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT CC/MCC | $141,510 | $141,510 | — | — | 1 |
| RX-128898 | OCRELIZUMAB 300 MG/10ML IV SOLN | $112,916 | $112,916 | — | — | 6 |
| 155 | OTHER EAR, NOSE, MOUTH AND THROAT DIAGNOSES WITH CC | $109,730 | $109,730 | — | — | 0 |
| 391 | ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MCC | $98,547 | $98,547 | — | — | 7 |
| 280 | ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | $92,540 | $92,540 | — | — | 7 |
| 726 | BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC | $91,231 | $91,231 | — | — | 3 |
| RX-97701 | CABAZITAXEL 60 MG/1.5ML IV SOLN | $86,427 | $86,427 | — | — | 16 |
| RX-152966 | NADOFARAGENE FIRADENOVEC-VNCG 300000000000 VP/ML IS SUSP | $86,250 | $86,250 | — | — | 5 |
| 475 | AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH CC | $85,959 | $85,959 | — | — | 3 |
| 884 | ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY | $81,459 | $81,459 | — | — | 11 |
| RX-141155 | PERTUZ-TRASTUZ-HYALURON-ZZXF 80-40-2000 MG-MG-U/ML SC SOLN | $76,276 | $76,276 | — | — | 1 |
| 329 | MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MCC | $73,260 | $73,260 | — | — | 12 |
| 516 | OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH CC | $68,684 | $68,684 | — | — | 4 |
| 629 | OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH CC | $65,683 | $65,683 | — | — | 3 |
| 617 | AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH CC | $64,552 | $64,552 | — | — | 1 |
| 042 | PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITHOUT CC/MCC | $63,676 | $63,676 | — | — | 0 |
| 876 | O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS | $63,244 | $63,244 | — | — | 8 |
| RX-125039 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $62,569 | $62,569 | — | — | 6 |
| 853 | INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | $61,107 | $61,107 | — | — | 19 |
| RX-134503 | CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN | $60,751 | $60,751 | — | — | 11 |
| RX-103786 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $60,203 | $60,203 | — | — | 13 |
| 252 | OTHER VASCULAR PROCEDURES WITH MCC | $57,568 | $57,568 | — | — | 5 |
| RX-140530 | DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN | $57,118 | $57,118 | — | — | 13 |
| 064 | INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC | $55,370 | $55,370 | — | — | 17 |
| 486 | KNEE PROCEDURES WITH PRINCIPAL DIAGNOSIS OF INFECTION WITH CC | $55,317 | $55,317 | — | — | 9 |
| 288 | ACUTE AND SUBACUTE ENDOCARDITIS WITH MCC | $54,543 | $54,543 | — | — | 5 |
| 374 | DIGESTIVE MALIGNANCY WITH MCC | $54,398 | $54,398 | — | — | 8 |
| RX-430040 | LETS GEL KIT | $54,050 | $54,050 | — | — | 18 |
| 296 | CARDIAC ARREST, UNEXPLAINED WITH MCC | $51,862 | $51,862 | — | — | 8 |
| 542 | PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MCC | $51,127 | $51,127 | — | — | 2 |
| RX-141154 | PERTUZ-TRASTUZ-HYALURON-ZZXF 60-60-2000 MG-MG-U/ML SC SOLN | $50,848 | $50,848 | — | — | 1 |
| 478 | BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC | $50,122 | $50,122 | — | — | 2 |
| 656 | KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC | $47,917 | $47,917 | — | — | 11 |
| 867 | OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC | $47,346 | $47,346 | — | — | 3 |
| RX-115920 | OBINUTUZUMAB 1000 MG/40ML IV SOLN | $47,206 | $47,206 | — | — | 13 |
| RX-45400 | NATALIZUMAB 300 MG/15ML IV CONC | $47,204 | $47,204 | — | — | 17 |
| RX-10681 | ALTEPLASE 100 MG IV SOLR | $46,999 | $46,999 | — | — | 5 |
| RX-122173 | INTERFERON BETA-1A 30 MCG/0.5ML IM PSKT | $46,340 | $46,340 | — | — | 21 |
| 645 | ENDOCRINE DISORDERS WITHOUT CC/MCC | $46,255 | $46,255 | — | — | 12 |
| 843 | OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC | $44,833 | $44,833 | — | — | 7 |
| RX-136068 | ATEZOLIZUMAB 840 MG/14ML IV SOLN | $43,798 | $43,798 | — | — | 5 |
| RX-131670 | NIVOLUMAB 240 MG/24ML IV SOLN | $43,728 | $43,728 | — | — | 10 |
| 474 | AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH MCC | $43,711 | $43,711 | — | — | 2 |
| RX-24801 | LEUPROLIDE ACETATE (4 MONTH) 30 MG IM KIT | $43,667 | $43,667 | — | — | 23 |
| 503 | FOOT PROCEDURES WITH MCC | $43,426 | $43,426 | — | — | 18 |
Showing top 50 of 11,844 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.